查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1456973

全球经肠营养设备市场 – 2024 年至 2029 年预测

Global Enteral Feeding Devices Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 165 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

2022年经肠营养设备市场价值为35.23亿美元，预计复合年增长率为4.81%，到2029年市场规模将达到48.95亿美元。

经肠营养装置是一种将液体营养物质直接输送到胃肠道的医疗设备，使患者能够透过管子获得必需的营养物质，如蛋白质、碳水化合物、脂肪、维生素和矿物质。这些设备通常用于医院、长期照护机构和居家医疗环境，以确保营养控制和测量。

这是由于早产儿数量的增加、开发中国家医疗设施的快速改善以及糖尿病、乙型肝炎、丙型肝炎、癌症、类风湿性关节炎、胃肠道疾病等慢性病患病率的上升所推动的。和 CVD。这些因素预计将推动显着增长。例如，胃肠道和肝臟疾病是中东和北非国家死亡和残疾的主要原因。阿富汗、巴基斯坦和埃及的 GLD 患者数量最多。在该地区大多数国家，腹泻病已被胃肠道癌症和肝硬化所取代。然而，在一些国家，包括阿富汗、巴基斯坦、土库曼斯坦、埃及和也门，除了非传染性 GILD 和癌症之外，传染性 GILD 继续在死亡率和发病率中占主导地位。 GILD患者数量的增加显着增加了对医疗服务和设备（包括经肠营养设备）的需求。

此外，居家医疗和门诊医疗保健中越来越多地采用经肠营养设备，预计将进一步推动预测期内的显着增长。然而，与经肠营养设备相关的併发症、经肠营养报销不足以及消费者对使用经肠营养设备的程序缺乏认识等因素预计将阻碍市场成长。

市场驱动因素：

  • 老年人口不断增加，慢性病盛行率上升。

由于各种神经和肌肉骨骼疾病而卧床不起的老年人口数量不断增加，预计将进一步推动市场成长。在澳洲等已开发国家，老年人口持续成长，预计到 2057 年将增加一倍以上。这种疾病的盛行率逐年增加，这可能会对经肠营养设备产生巨大的需求。

此外，心血管疾病、糖尿病和癌症等自体免疫疾病的盛行率不断增加，预计市场对预填充式注射器的巨大需求。根据世界卫生组织 (WHO) 估计，约有 1,790 万人因心血管疾病增加而死亡，约占全球死亡人数的 32%。

此外，腹泻疾病的增加预计也将推动整体市场的成长。据世界卫生组织 (WHO) 称，腹泻病每年导致约 525,000 名五岁以下儿童死亡。由于营养不良以及食物和水源污染，腹泻病是全世界儿童死亡的主要原因。全球有 7.8 亿人缺乏饮用水，25 亿人缺乏改善的卫生设施。

预计北美将主导整个市场

从地区来看，经肠营养设备市场分为北美、欧洲、中东和非洲、南美和亚太地区。印度和中国等国家预计在预测期内将出现可观的市场成长。这一增长归因于糖尿病盛行率的上升，印度20-79岁年龄层的糖尿病患者有7,700万，其次是中国，有1.16亿成年人患有糖尿病。这一增长主要由西太平洋和东南亚国家贡献（资料来源：IDF）。由于在医疗保健领域采用先进的治疗方法，该设备的采用率越来越高，预计北美将主导整个市场的成长。此外，该地区慢性病的高盛行率将进一步增加对经肠营养设备的需求。 2020年，美国估计有186万人被诊断出罹患癌症，超过55,000人死于癌症（资料来源：美国癌症研究所）。北美经肠营养设备市场预计将受到政府有利的财政支持以及美国持续的研究、预防和治疗的推动。

目录

第一章 简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现
  • CXO观点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章全球经肠营养设备市场：按类型

  • 介绍
  • 肠道餵食帮浦
    • 市场机会和趋势
    • 成长前景
    • 地域盈利
  • 经肠营养管
    • 市场机会和趋势
    • 成长前景
    • 地域盈利
  • 肠内注射器
    • 市场机会和趋势
    • 成长前景
    • 地域盈利

第六章经肠营养装置全球市场：依年龄组

  • 介绍
  • 成人
    • 市场机会趋势
    • 成长前景
    • 地域盈利
  • 儿童
    • 市场机会和趋势
    • 成长前景
    • 地理收益

第七章经肠营养装置全球市场：依应用

  • 介绍
  • 消化内科
    • 市场机会和趋势
    • 成长前景
    • 地域盈利
  • 瘤
    • 市场机会和趋势
    • 成长前景
    • 地理收益
  • 神经病学
    • 市场机会和趋势
    • 成长前景
    • 地域盈利
  • 代谢亢进
    • 市场机会和趋势
    • 成长前景
    • 地域盈利
  • 糖尿病
    • 市场机会和趋势
    • 成长前景
    • 地理收益
  • 其他的
    • 市场机会和趋势
    • 成长前景
    • 地域盈利

第八章经肠营养设备的全球市场：依最终用户分类

  • 介绍
  • 医院
    • 市场机会和趋势
    • 成长前景
    • 地域盈利
  • 居家医疗
    • 市场机会和趋势
    • 成长前景
    • 地域盈利
  • 门诊就诊环境
    • 市场机会和趋势
    • 成长前景
    • 地域盈利

第九章经肠营养设备全球市场：按地区

  • 介绍
  • 北美洲
    • 按类型
    • 按年龄组别
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 南美洲
    • 按类型
    • 按年龄组别
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 欧洲
    • 按类型
    • 按年龄组别
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 中东/非洲
    • 按类型
    • 按年龄组别
    • 按用途
    • 按最终用户
    • 按国家/地区
  • 亚太地区
    • 按类型
    • 按年龄组别
    • 按用途
    • 按最终用户
    • 按国家/地区

第十章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十一章 公司简介

  • GBUK Enteral Ltd.
  • Nestle SA
  • B.Braun Melsungen AG
  • Cardinal Health, Inc.
  • 维贡（英国）有限公司
  • Avanos Medical, Inc.
  • Rockfield Medical Device
  • Applied Medical Technology, Inc.
  • Fresenius SE & Co. KGaA
  • Conmed Corporation
  • Moog Inc.
简介目录
Product Code: KSI061611549

The global enteral feeding devices market is evaluated at US$3.523 billion for 2022 and is projected to grow at a CAGR of 4.81% to reach the market size of US$4.895 billion by 2029.

Enteral feeding devices are medical devices that deliver liquid nutrients directly into the gastrointestinal tract, allowing patients to receive essential nutrients like proteins, carbohydrates, fats, vitamins, and minerals through a tube. These devices are commonly used in hospitals, long-term care facilities, and home healthcare settings to ensure controlled and measured administration of nutrition.

Factors that are expected to drive this notable growth are an increasing number of premature births, rapid improvements in medical facilities in developing countries, and the rising prevalence of chronic diseases like diabetes mellitus, hepatitis B and C, cancer, rheumatoid arthritis, gastrointestinal disease, and CVDs. For instance, gastrointestinal and liver diseases are major causes of death and disability in the Middle East and North African countries. The number of patients suffering from GLDs is highest in Afghanistan, Pakistan, and Egypt. Diarrheal diseases have been replaced by gastrointestinal cancers and cirrhosis in most countries in the region. However, in several countries including Afghanistan, Pakistan, Turkmenistan, Egypt, and Yemen, communicable GILDs are still among the top causes of mortality and morbidity in addition to non-communicable GILDs and cancers. The rising prevalence of GILD cases has significantly increased the demand for healthcare services and equipment, including enteral feeding devices.

Moreover, the rising adoption of enteral feeding devices in the home and ambulatory care settings is further projected to drive this notable growth during the forecast period. However, factors such as complications associated with enteral feeding devices, insufficient reimbursement for enteral nutrition, and lack of consumer awareness for procedures using enteral feeding devices are expected to hinder market growth.

MARKET DRIVER:

  • Growing geriatric population and rise in prevalence of chronic diseases.

A rising geriatric population that gets bedridden due to various neurological and musculoskeletal disorders is further expected to boost the market growth. In developed countries like Australia, the older population continues to grow and is projected to more than double by 2057. The prevalence of the disease is rising from year to year which will create a huge demand for enteral feeding devices.

Further, the rising prevalence of autoimmune diseases such as cardiovascular disease, diabetes, and cancer is expected to create a huge demand for prefilled syringes in the market. According to the World Health Organization, it was estimated that around 17.9 million people died due to the increasing cases of cardiovascular disease which represents around 32% of all global deaths.

Additionally, growing cases of diarrheal disease are further anticipated to drive the overall market growth. According to the World Health Organization, diarrhoeal disease kills around 525,000 children under five every year. It is a leading cause of child mortality in the world which results from malnutrition and contaminated food and water sources. Worldwide, 780 million individuals lack access to drinking water, and 2.5 billion lack improved sanitation.

Key developments

  • September 2023- Cardinal Health has announced the launch of the Kangaroo OMNI enteral feeding pump, offering patients more personalized options for their enteral feeding journey. The first and attitude-independent enteral feeding system in the US, Kangaroo OMNI delivers thick, homogenized, and blended formulas. Its compact size, versatility to feed, flush, and hydrate, and 30-day feeding history make it a convenient pump for patients and caregivers, from hospital to home. The pump is designed to meet the needs of patients and caregivers.
  • November 2022- Medela has donated products to 60 Ronald McDonald House locations in Australia, China, the UK, and the USA to improve maternal and infant health outcomes. The donation will support 15,000 breastfeeding families and includes Symphony breast pumps, kits, and accessories. Medela also partnered with Ronald McDonald House Charities to donate NICU supplies under its breastfeeding business unit. The company's focus is on fighting infant mortality and malnutrition, protecting vulnerable infants, increasing access to quality healthcare, education, and resources, and promoting gender equality and inclusion.

North America is anticipated to dominate the overall market

Geographically, the global enteral feeding devices market has been classified into North America, Europe, the Middle East and Africa, South America, and the Asia Pacific. Countries like India and China are anticipated to have considerable market growth during the forecast period. The growth is attributed due to the rise in the prevalence of diabetes, India has 77 million people that are suffering from diabetes in the 20-79 years age group followed by China which has 116 million adults with diabetes. The growth is mainly contributed by the countries that lie in the western pacific and southeast Asia (Source: IDF). North America is anticipated to dominate the overall market growth due to the rising adoption of this device followed by advanced treatment approaches in healthcare. Moreover, the high prevalence of the chronic disease across the region will further increase the demand for enteral feeding devices. In 2020, an estimated 1.86 million cases of cancer were diagnosed in the United States and more than 55,000 people died from the disease (Source: National Cancer Institute). The enteral feeding devices market in North America is projected to be driven by favorable funding from the government and continuous research, prevention, and treatment in the United States.

Market Segments

By Type

  • Enteral Feeding Pumps
  • Enteral Feeding Tubes
  • Enteral Syringes

By Age Group

  • Adult
  • Pediatric

By Application

  • Gastroenterology
  • Oncology
  • Neurology
  • Hypermetabolism
  • Diabetes
  • Others

By End-User

  • Hospitals
  • Home Care
  • Ambulatory Care Settings

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • U.K.
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL ENTERAL FEEDING DEVICES MARKET, BY TYPE

  • 5.1. Introduction
  • 5.2. Enteral Feeding Pumps
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Enteral Feeding Tubes
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Enteral Syringes
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness

6. GLOBAL ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP

  • 6.1. Introduction
  • 6.2. Adult
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Paediatric
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness

7. GLOBAL ENTERAL FEEDING DEVICES MARKET, BY APPLICATION

  • 7.1. Introduction
  • 7.2. Gastroenterology
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Oncology
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Neurology
    • 7.4.1. Market Opportunities and Trends
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness
  • 7.5. Hypermetabolism
    • 7.5.1. Market Opportunities and Trends
    • 7.5.2. Growth Prospects
    • 7.5.3. Geographic Lucrativeness
  • 7.6. Diabetes
    • 7.6.1. Market Opportunities and Trends
    • 7.6.2. Growth Prospects
    • 7.6.3. Geographic Lucrativeness
  • 7.7. Others
    • 7.7.1. Market Opportunities and Trends
    • 7.7.2. Growth Prospects
    • 7.7.3. Geographic Lucrativeness

8. GLOBAL ENTERAL FEEDING DEVICES MARKET, BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals
    • 8.2.1. Market Opportunities and Trends
    • 8.2.2. Growth Prospects
    • 8.2.3. Geographic Lucrativeness
  • 8.3. Home Care
    • 8.3.1. Market Opportunities and Trends
    • 8.3.2. Growth Prospects
    • 8.3.3. Geographic Lucrativeness
  • 8.4. Ambulatory Care Settings
    • 8.4.1. Market Opportunities and Trends
    • 8.4.2. Growth Prospects
    • 8.4.3. Geographic Lucrativeness

9. GLOBAL ENTERAL FEEDING DEVICES MARKET, BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Type
    • 9.2.2. By Age Group
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
      • 9.2.5.1. United States
        • 9.2.5.1.1. Market Opportunities and Trends
        • 9.2.5.1.2. Growth Prospects
      • 9.2.5.2. Canada
        • 9.2.5.2.1. Market Opportunities and Trends
        • 9.2.5.2.2. Growth Prospects
      • 9.2.5.3. Mexico
        • 9.2.5.3.1. Market Opportunities and Trends
        • 9.2.5.3.2. Growth Prospects
  • 9.3. South America
    • 9.3.1. By Type
    • 9.3.2. By Age Group
    • 9.3.3. By Application
    • 9.3.4. By End User
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
        • 9.3.5.1.1. Market Opportunities and Trends
        • 9.3.5.1.2. Growth Prospects
      • 9.3.5.2. Argentina
        • 9.3.5.2.1. Market Opportunities and Trends
        • 9.3.5.2.2. Growth Prospects
      • 9.3.5.3. Others
        • 9.3.5.3.1. Market Opportunities and Trends
        • 9.3.5.3.2. Growth Prospects
  • 9.4. Europe
    • 9.4.1. By Type
    • 9.4.2. By Age Group
    • 9.4.3. By Application
    • 9.4.4. By End User
    • 9.4.5. By Country
      • 9.4.5.1. United Kingdom
        • 9.4.5.1.1. Market Opportunities and Trends
        • 9.4.5.1.2. Growth Prospects
      • 9.4.5.2. Germany
        • 9.4.5.2.1. Market Opportunities and Trends
        • 9.4.5.2.2. Growth Prospects
      • 9.4.5.3. France
        • 9.4.5.3.1. Market Opportunities and Trends
        • 9.4.5.3.2. Growth Prospects
      • 9.4.5.4. Italy
        • 9.4.5.4.1. Market Opportunities and Trends
        • 9.4.5.4.2. Growth Prospects
      • 9.4.5.5. Spain
        • 9.4.5.5.1. Market Opportunities and Trends
        • 9.4.5.5.2. Growth Prospects
      • 9.4.5.6. Others
        • 9.4.5.6.1. Market Opportunities and Trends
        • 9.4.5.6.2. Growth Prospects
  • 9.5. Middle East and Africa
    • 9.5.1. By Type
    • 9.5.2. By Age Group
    • 9.5.3. By Application
    • 9.5.4. By End User
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
        • 9.5.5.1.1. Market Opportunities and Trends
        • 9.5.5.1.2. Growth Prospects
      • 9.5.5.2. UAE
        • 9.5.5.2.1. Market Opportunities and Trends
        • 9.5.5.2.2. Growth Prospects
      • 9.5.5.3. Others
        • 9.5.5.3.1. Market Opportunities and Trends
        • 9.5.5.3.2. Growth Prospects
  • 9.6. Asia Pacific
    • 9.6.1. By Type
    • 9.6.2. By Age Group
    • 9.6.3. By Application
    • 9.6.4. By End User
    • 9.6.5. By Country
      • 9.6.5.1. Japan
        • 9.6.5.1.1. Market Opportunities and Trends
        • 9.6.5.1.2. Growth Prospects
      • 9.6.5.2. China
        • 9.6.5.2.1. Market Opportunities and Trends
        • 9.6.5.2.2. Growth Prospects
      • 9.6.5.3. India
        • 9.6.5.3.1. Market Opportunities and Trends
        • 9.6.5.3.2. Growth Prospects
      • 9.6.5.4. South Korea
        • 9.6.5.4.1. Market Opportunities and Trends
        • 9.6.5.4.2. Growth Prospects
      • 9.6.5.5. Taiwan
        • 9.6.5.5.1. Market Opportunities and Trends
        • 9.6.5.5.2. Growth Prospects
      • 9.6.5.6. Thailand
        • 9.6.5.6.1. Market Opportunities and Trends
        • 9.6.5.6.2. Growth Prospects
      • 9.6.5.7. Indonesia
        • 9.6.5.7.1. Market Opportunities and Trends
        • 9.6.5.7.2. Growth Prospects
      • 9.6.5.8. Others
        • 9.6.5.8.1. Market Opportunities and Trends
        • 9.6.5.8.2. Growth Prospects

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. GBUK Enteral Ltd.
  • 11.2. Nestle SA
  • 11.3. B.Braun Melsungen AG
  • 11.4. Cardinal Health, Inc.
  • 11.5. Vygon (UK) Ltd
  • 11.6. Avanos Medical, Inc.
  • 11.7. Rockfield Medical Device
  • 11.8. Applied Medical Technology, Inc.
  • 11.9. Fresenius SE & Co. KGaA
  • 11.10. Conmed Corporation
  • 11.11. Moog Inc.